Seeking Alpha

Myriad Genetics (MYGN): FQ1 EPS of $0.24 beats by $0.01. Revenue of $92M (+8%) vs. $93M. (PR)

Myriad Genetics (MYGN): FQ1 EPS of $0.24 beats by $0.01. Revenue of $92M (+8%) vs. $93M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)